Key result
Higher variability in total cholesterol and LDL-c is linked to increased risk of incident dementia.
Why the study?
Is year-to-year lipid variability associated with the risk of cognitive decline and dementia in community-dwelling older adults?
Observational (n=19,114)
Yes
Is year-to-year lipid variability associated with the risk of cognitive decline and dementia in community-dwelling older adults?
Answers are grounded in this paper and cite their sources.
Year-to-year variability in total cholesterol and LDL-c may serve as a novel biomarker for incident dementia and cognitive decline in older adults.
BACKGROUND AND OBJECTIVES: Lipid metabolism in older adults is affected by various factors including biological aging, functional decline, reduced physiologic reserve, and nutrient intake. The dysregulation of lipid metabolism could adversely affect brain health. This study investigated the association between year-to-year intraindividual lipid variability and subsequent risk of cognitive decline and dementia in community-dwelling older adults. METHODS: ASPirin in Reducing Events in the Elderly (ASPREE) was a randomized trial of aspirin, involving 19,114 participants aged 65 years and older from Australia and the United States who were free of dementia and major cognitive impairment. ASPREE-eXTension is the post-trial observational follow-up of participants, currently to a maximum of 11 years. This post hoc analysis included participants who had lipid levels measured at baseline and in years 1, 2, and 3. Year-to-year variability in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and triglycerides over the first 3 years was quantified using variability independent of the mean. Individuals who initiated or discontinued lipid-lowering therapy during this period were excluded. Multivariable Cox proportional hazards regression was used to analyze associations with incident dementia, adjudicated by expert panels, and cognitive impairment with no dementia (CIND) confirmed by a battery of cognitive tests, occurring after year 3. A linear mixed model was used for assessing the association with changes in 4 cognitive function domains, including global, memory, processing speed, verbal fluency, and a composite score from baseline to the end of follow-up. No strong evidence was found for an association of HDL-c and triglyceride variability with dementia and cognitive change. DISCUSSION: Tracking variability of TC and LDL-c may serve as a novel biomarker of incident dementia and cognitive decline in older adults.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) conducted an observational in Cognitive decline and dementia (n=19,114). Year-to-year lipid variability was evaluated on Incident dementia and cognitive impairment with no dementia (CIND) (p=<0.001). Year-to-year variability in total cholesterol and LDL-c was associated with incident dementia and cognitive decline, whereas HDL-c and triglyceride variability showed no strong association.
Synapse has enriched 10 related papers. Consider them for comparative context: